Quote | Endocyte Inc. (NASDAQ:ECYT)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | Endocyte Inc. (NASDAQ:ECYT)
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Despite being a tradi...
I have been hesitant about buying into Progenics Pharmaceuticals ( PGNX ) due to my insufficient knowledge about the advancements of radiopharmaceuticals in the oncology arena. Perhaps it is all the hype of immuno-oncology and the rise of gene therapy that caused me to believe that radiopharma...
Message Board Posts | Endocyte Inc. (NASDAQ:ECYT)
|Some serious money here||PennyStock Alert||investorshub||09/17/2019 3:35:04 PM|
|I took short position. This has to pullback||PennyStock Alert||investorshub||09/17/2019 1:51:27 PM|
|It isn't moving much.||BMM||investorshub||10/22/2018 3:19:44 PM|
|Good buy here||dannyzee84||investorshub||10/19/2018 1:40:35 PM|
|ECYT buy 17.53||stocktrademan||investorshub||09/23/2018 11:01:23 PM|
Endocyte Inc. Company Name:
ECYT Stock Symbol:
Endocyte Inc. Website:
Entered into agreement and plan of merger with Novartis AG for $2.1Billion WEST LAFAYETTE, Ind., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics...
WEST LAFAYETTE, Ind., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team will present at two upcoming investor conferences ...